FDA Clears First Oral HER2 NSCLC Drug, Zongertinib News FDA Clears First Oral HER2 NSCLC Drug, Zongertinib Mursalin Pathan August 14, 2025 0 In a major step forward for lung cancer treatment, the U.S. Food and Drug Administration (FDA) has... Read More Read more about FDA Clears First Oral HER2 NSCLC Drug, Zongertinib
